US Ad Watchdog Group May Allow Reopening Of Reviews With New Data
This article was originally published in The Pink Sheet & The Rose Sheet
The private National Advertising Division is allowing marketers to petition to reopen closed cases if they have new studies or other data supporting ad claims, though the bar for re-review is high, says NAD Director Laura Brett.
You may also be interested in...
Biodene maker GSK challenged Sanofi's ACT Dry Mouth advertising and both companies find disappointments in the Better Business Bureaus' advertising division's review.
GlaxoSmithKline will discontinue claim P&G's Metamucil product causes excess gas and it Citrucel doesn't after P&G presented evidence that met NAD's standard for reopening a review. The industry self-regulation organization found GSK could no longer support its claim.
Dubious supplement ad claims that have driven FTC enforcement in the sector for some time likely will continue as three commission seats are filled, says advertising practices official Richard Cleland.